2
US Debut for Synova's LCS 305 Highly Dynamic 5-axis Laser Machining Center
mehr
Storys aus NJ
-
Sprache:
Englisch
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
Comodo and Distilogix Partner to Deliver Zero Trust Endpoint Protection to Enterprises in the Middle East, Africa and the Eastern European Region
Bloomfield, NJ (ots) - --News Direct-- Comodo Security Solutions, a leading provider of endpoint protection, today announced that they have partnered withDistilogix Distribution to boost presence and better support enterprise customers in the Middle East, Africa, and the Eastern European region. Both companies are ...
mehrQX Global Group Acquires Management Consulting & Advisory Services Firm Chazey Partners
Bloomfield, NJ, USA / London, England (ots) - --News Direct-- Together QX Global Group and Chazey Partners will provide end-to-end Business Transformation, Digital Services & Intelligent Automation, and Business Process Outsourcing (BPO) for Fortune 1000 companies and public sector organizations, including higher education, across the globe. QX Global Group, a Top 100 ...
mehr- 2
SYNOVA Announces Grand Opening of its New US Headquarters
mehr Eisai Oncology & Helsinn Group to Present New CINV Research at 2014 International Symposium on Supportive Care in Cancer
Woodcliff Lake, NJ, and Lugano, Switzerland (ots) - Eisai Inc. and Helsinn Group announced today that several abstracts highlighting data analyses of NEPA, an investigational oral fixed- dose combination of netupitant and palonosetron being evaluated for the prevention of chemotherapy-induced nausea and vomiting ...
mehrHelsinn Group and Eisai announce FDA acceptance of New Drug Application for investigational compound netupitant 300 mg + palonosetron 0.50 mg (NEPA)
Lugano, Switzerland/Woodcliff Lake, NJ, USA (ots) - Seeking indication for prevention of chemotherapy-induced nausea and vomiting Helsinn Group and Eisai Inc. today announced that the U.S. Food and Drug Administration (FDA) accepted for review the submission of the New Drug Application (NDA) for the investigational ...
mehrHelsinn and Eisai Inc. Announce Top-Line Results for Pivotal Studies of the Investigational Fixed-Dose Combination of Netupitant and Palonosetron for Prevention of Chemotherapy-Induced Nausea and Vomiting
Lugano, Switzerland and Woodcliff Lake, NJ, USA (ots) - Data to Be Presented at Annual Meeting of the American Society of Clinical Oncology (ASCO) Helsinn Group and Eisai Inc. announced today top-line results from Helsinn's pivotal clinical studies investigating the oral fixed-dose combination of netupitant and ...
mehrHertz franchises Swiss Business to Emil Frey Group
Park Ridge, NJ/Zurich, Switzerland (ots) - The Hertz Corporation (NYSE:HTZ) the world's largest general use car rental brand, and Emil Frey Group have signed an agreement for Emil Frey Group to join Hertz's global franchising network and purchase the Hertz car rental business in Switzerland, representing a total of 30 locations. Mark P. Frissora, Chairman and Chief Executive Officer for The Hertz Corporation, said: "Hertz ...
mehrWatson to Acquire Actavis Group for EUR 4.25 Billion
Parsippany, NJ (ots) - - Creates 3rd largest global generics company - - ~$8.0 billion anticipated pro forma combined revenue in 2012 - - Significantly increases scale of Watson's ex-U.S. generic business- - Accelerates revenue and earnings growth - - Immediately accretive to non-GAAP earnings, before synergies - - Greater than $300 million annual synergies anticipated within 3 years - - Strong combined cash flow allows ...
mehrHelsinn Group and Eisai Inc. announce start of phase III clinical program of oral fixed-dose combination of Netupitant/Palonosetron (300mg/0.50mg) for prevention of CINV
Lugano, Switzerland and Woodcliff Lake, NJ, USA (ots) - Helsinn Group and Eisai Inc. announced today that Helsinn has commenced a multi-centered Phase III clinical study program investigating the Netupitant/Palonosetron (300mg/0.50mg) oral fixed-dose combination for the prevention of chemotherapy-induced nausea and ...
mehr
1